more frequent side effects
gastrointestinal hemorrhage
genitourinary tract hemorrhage
comprehensive list of adverse effects
following side effects
taking
check
doctor
nurse
incidence of major hemorrhagic events among heparinized patients with acute myocardial infarction
cardiac catheterization in the thrombolysis in myocardial infarction
timi
study
age
averaging
patients
years
years
values
gissi
data
overall incidence of bleeding
alteplase
active ingredient
activase
heparin
concomitant administration of heparin
incidence of stroke
incidence of major bleeding
patients
streptokinase
heparin therapy
large study of patients with acute thrombotic
embolic stroke
incidence of hemorrhagic infarction
parenchymal hematoma
patients in this study
neurological worsening
hemorrhagic infarction
brain
parenchymal hematoma
patients
limited data in which mg of alteplase
patients
documented middle cerebral artery
intracranial internal carotid artery occlusion
incidence of hemorrhagic infarction without clinical deterioration
fatal parenchymal hemorrhage
serious puncture site hemorrhage
patients
overall incidence of alteplase-induced symptomatic intracerebral hemorrhage
ich
most studies
overall risk of symptomatic ich with the use
alteplase therapy
expertise of the
treating clinician
report
risk of symptomatic ich
protocol guidelines
deviating from protocol guidelines
other studies
findings
risk of ich
elderly patients
thrombolytics for acute mi
alternative reperfusion strategy
i.
e.
angioplasty
patient population
hematologic side effect
bleeding
common adverse event in all
approved indications
incidence of bleeding among patients with acute myocardial infarction
alteplase
aspirin
heparin
blood loss of greater than ml
patients
gastrointestinal tract
genitourinary tract
ecchymosis
epistaxis
retroperitoneal bleeding
patients
incidence of alteplase-associated intracranial hemorrhagic
ich
patients with acute myocardial infarction
administration of mg over hours
incidence of stroke
mg over minutes
rate
mg over minutes
rate of ich
ich in patients with acute ischemic stroke
patients
placebo
symptomatic ich
sudden clinical worsening
subsequent ct verification of ich
hours
receiving alteplase
stroke
patients
ami
receiving
hour infusion
accelerated infusion
rare cases of atheroembolic events
use of this drug
other lytic agents
bleeding
therapy with alteplase
pressure
alteplase
heparin
arterial punctures
particular concern
upper extremity
manual compression
usual precautions
procedures
following arterial catheterization
other invasive procedures
non-compressible venous sites
cardiovascular-related side effects
patient with an acute myocardial infarction
ami
pulmonary embolism
events
sequelae of the disease
relationship
drug
reperfusion arrhythmias
including sinus bradycardia
idioventricular rhythm
premature ventricular depolarizations
ventricular tachycardia
alteplase
incidence of in-hospital mortality
ventricular failure
postinfarction angina
reinfarction
ischemic events in patients with ami
alteplase-associated cases of recurrent thrombosis
reinfarction
reinfarction
embolization
lysed thrombi
reformation of thrombi
elevated thrombin-antithrombin-iii levels during alteplase
active ingredient
activase
therapy
adjunctive therapy with continuous heparin
risk of an alteplase-induced hypercoagulable state
angioedema
alteplase therapy in patients with acute ischemic stroke
alteplase
combination with an angiotensin-converting enzyme inhibitor
orolingual angioedema
most cases
progressive requiring
progressive requiring urgent intubation
recurrent hemopericardium
cardiac tamponade
massive hemorrhagic mi
death from cardiogenic shock
use of some thrombolytic agents
cholesterol embolization syndrome
peripheral cyanosis
alteplase therapy
mortality rate among patients in the thrombolysis in myocardial infarction
timi
study
age
averaging
patients
years
years
risk factors for death
female gender
diabetes mellitus
extensive coronary artery disease
history of congestive heart failure
persistent chest pain after alteplase administration
low systolic blood pressure at presentation
age
life-threatening nervous system side effect
hemorrhagic stroke
patients with an acute myocardial infarction
administration of mg over hours
incidence of stroke
mg over minutes
incidence
mg over minutes
rate of ich
incidence
patients with thrombotic stroke
reports as high
worsening
worsening neurologic status
side effects
rare cases of intracerebral hemorrhage
use of t-pa in patients with cerebral amyloid angiopathy
cases of headache
subdural hematoma
alteplase
active ingredient
activase
recurrent intracerebral embolization
following alteplase
patient with dilated cardiomyopathy
alteplase
lysis
embolization
detached intracranial thrombi
stroke
patients
ami
receiving
hour infusion
accelerated infusion
rare cases of atheroembolic events
use of this drug
other lytic agents
retrospective meta-analysis of patients with intracranial hemorrhage
ich
n
alteplase
n
following
following independent predictors for ich
odds ratio
age over years
body weight below kg
hypertension on admission
probability of ich
number of risk factors
other studies
data
finding
higher killip classification
occurrence of anterior myocardial infarction as additional risk factors
data
other possible risk factors
extensive peripheral vascular disease
diabetes
use of oral anticoagulants
year-old beekeeper with acute myocardial infarction
urticaria
tongue
neck edema within minutes
following administration of glyceryl trinitrate
nifedipine
aspirin
alteplase
active ingredient
activase
investigations
normal complement
quantitative measurements
absence
circulating
circulating immune complexes
normal levels
circulating ige
absence of t-pa antibodies by elisa
intradermal skin testing with each drug
allergic response
anaphylactoid reaction
direct chemical reaction
patient
history of atopy
authors
clinicians
alteplase
atopic individuals
possibility of an anaphylactoid reaction
resuscitative measures
year-old woman with systemic lupus erythematosus
deep vein thrombosis
throat tightness
dyspnea
dysphagia within hours
receiving alteplase therapy
subconjunctival bullous edema of the left eye
angioedema of the tongue
face
neck
upper lip
associated laboratory findings
decreased c
c esterase inhibitor levels
baseline
patient
angioedema
hours after discontinuation of alteplase
initiation of steroid
antihistamine therapy
separate report
cases of anaphylactic reactions
following treatment of consecutive patients
treatment of ischemic stroke
hypersensitivity reactions
patients
cause-and-effect relationship between anaphylaxis
alteplase
gi
side effects
gi bleeding
renal biopsy in a
year-old man with a history of angina
hypertension
hypercholesterolemia
acute renal failure after alteplase
active ingredient
activase
therapy for an acute myocardial infarction
needle-shaped cholesterol crystals in small artery intima
mild focal segmental mesangial cell proliferation
tubular atrophy
interstitial fibrosis
patient
required maintenance hemodialysis
rare cases of cholesterol crystal embolization
syndrome-associated renal failure
alteplase therapy
bleeding
frequent side effect
alteplase
active ingredient
activase
therapy
arterial punctures
particular concern
upper extremity
manual compression
arterial puncture
usual precautions
procedures
following arterial catheterization
other invasive procedures
non-compressible venous sites
hepatic side effects
cases
reports of hepatic cholesterol embolization syndrome
local inflammation
ecchymosis
extravasation during alteplase
active ingredient
activase
infusion
bleeding from puncture sites
wounds
bleeding gums
coughing up blood
difficulty with breathing
swallowing
dizziness
headache
increased menstrual flow
vaginal bleeding
nosebleeds
paralysis
prolonged bleeding from cuts
tarry stools
dark brown urine
chills
confusion
fainting
fast heartbeat
fever
lightheadedness
pain in the chest
groin
legs
calves
pain
redness
swelling in the arm
leg
rapid, shallow breathing
severe, sudden headache
slurred speech
sudden loss of coordination
severe weakness
numbness in the arm
leg
unexplained shortness of breath
vision changes
anxiety
blue lips
fingernails
pale skin
blurred vision
chest pain
discomfort
chest pain
moving
left arm
neck
shoulder
convulsions
cool, sweaty skin
cough
coughing
pink frothy sputum
decreased urine output
dilated neck veins
extreme fatigue
hives
welts
itching
skin rash
hoarseness
increased sweating
hive-like swelling on the mouth
lips
tongue
loss of bladder control
muscle spasm
jerking of all extremities
nausea or vomiting
pain
discomfort in the arms
jaw
neck
puffiness
swelling of the eyelids
eyes
face
lips
tongue
redness of the skin
irregular breathing
heartbeat
sudden loss of consciousness
sweating
swelling of the face
fingers
feet
lower legs
ankles
unconsciousness
unusual tiredness
weakness
weight gain